Showing results (201-210 of 282) with videos related to

Sort By:
Pageof 29
Brain, Behavior, and Immunity|July 8, 2014
Early molecular and behavioral response to lipopolysaccharide in the WAG/Rij rat model of absence epilepsy and depressive-like behavior, involves interplay between AMPK, AKT/mTOR pathways and neuroinflammatory cytokine releaseEmilio Russo, Francesco Andreozzi, Rodolfo Iuliano, et al.
Pharmacological Research|December 11, 2017
Exploring the effects of DPP-4 inhibitors on the kidney from the bench to clinical trialsGiuseppe Coppolino, Christian Leporini, Laura Rivoli, et al.
International Journal of Molecular Sciences|December 23, 2022
Ranolazine Attenuates Brain Inflammation in a Rat Model of Type 2 DiabetesVelia Cassano, Martina Tallarico, Giuseppe Armentaro, et al.
Brain Research Bulletin|February 20, 2017
Cerebral small vessel disease predisposes to temporal lobe epilepsy in spontaneously hypertensive ratsEmilio Russo, Antonio Leo, Francesca Scicchitano, et al.
Updates in Surgery|November 3, 2012
Tryptase-positive mast cells and angiogenesis in keloids: a new possible post-surgical target for preventionMichele Ammendola, Valeria Zuccalà, Rosa Patruno, et al.
Neuropharmacology|December 17, 2008
T-type channel blocking properties and antiabsence activity of two imidazo[1,2-b]pyridazine derivatives structurally related to indomethacinMaria Grazia Rimoli, Emilio Russo, Mauro Cataldi, et al.
ACS Chemical Neuroscience|July 17, 2014
Nonpsychotropic plant cannabinoids, cannabidivarin (CBDV) and cannabidiol (CBD), activate and desensitize transient receptor potential vanilloid 1 (TRPV1) channels in vitro: potential for the treatment of neuronal hyperexcitabilityFabio Arturo Iannotti, Charlotte L Hill, Antonio Leo, et al.
Reviews on Recent Clinical Trials|March 16, 2018
Serum Complement C3 and Type 2 Diabetes in Rheumatoid Arthritis: A Case-Control StudyFrancesco Ursini, Salvatore D Angelo, Emilio Russo, et al.
Neuropsychiatric Disease and Treatment|August 15, 2015
Rare and very rare adverse effects of clozapinePasquale De Fazio, Raffaele Gaetano, Mariarita Caroleo, et al.
Cannabis and Cannabinoid Research|March 2, 2023
Cannabidiol Add-On in Glycosylphosphatidylinositol-Related Drug-Resistant EpilepsyAntonella Riva, Gianluca D'Onofrio, Angelica Pisati, et al.
Pageof 29